The Asian Scientist 100
Can Li
Institution
University of Hong Kong
Country
Hong Kong
Field
Engineering
Li is a recipient of the 2023 Croucher Tak Wah Mak Innovation Award for his research exploring the limitations of digital computers in performing tasks accomplished by the human brain, including recognising faces, reasoning based on vague information, and learning from experience.
(Photo: University of Hong Kong)
AWARDS
- 2023 Croucher Tak Wah Mak Innovation Award
Related articles
Study: Three-Drug Regimen Favored In Asia Is Useful In Preventing Clots After Angioplasty
A three-drug regimen, favored in Asia to prevent clots after angioplasty, is equal to a double-dose two-drug approach commonly used in Western countries, says new clinical research from Korea.
Humble Soy Has Big Effect On Lowering Blood Pressure, Study
Soy products, popular in Asian diets, have been shown to be beneficial in helping young adults lower their blood pressure.
Korean Scientists Use Dogs’ Sensitive Sniffer To Detect Rotting Food
South Korean scientists have developed a biomimetic detector based on receptors in the canine olfactory system to detect whether food is going bad.
New Salt-Tolerant Wheat Variety Shows 25% Improved Yield, Study
A team of Australian scientists has bred salt tolerance into a variety of durum wheat, resulting in improved grain yield by 25 percent on salty soils.
Japan Gives Philippines DepEd $1.5 Million For Preschool Education
A new ADB, Japan grant will see the construction of 60 preschools across the Philippines, giving hope to thousands of poor and malnourished children.
OMG! (Oh My Gulay) Campaign To Promote Eating Vegetables In Philippines
Celebrities are working with the Philippines government in a recently launched nationwide media campaign to lift the consumption of fresh produce and fight malnutrition among young people.
QIAGEN And Shanghai Jiao Tong To Open Translational Medicine Lab In Shanghai
QIAGEN and the Bio-X Center of Shanghai Jiao Tong University have signed an agreement to open a joint translational medicine lab in Shanghai.
China Biologic Receives SFDA Approval To Begin Human Fibrinogen Trials
China Biologic Products, Inc. has received SFDA approval to begin clinical trials for human fibrinogen as a treatment for congenital fibrinogen deficiency and acquired fibrinogen deficiency.
Asbestos: Deadly But Still Not Banned In Asia
Even though public health experts recognize how deadly asbestos can be, its use is on the rise in the construction industry throughout Asia, according to the U.S. Geological Survey.









